Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension

NCT04528056 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Sulfasalazine
DRUG: Ambrisentan
DRUG: Sulfasalazine's placebo
DRUG: Ambrisentan's placebo

Sponsor

RenJi Hospital